GenMark Diagnostics, Inc.·4

Jun 2, 6:34 PM ET

GLEESON CHRISTOPHER M 4

4 · GenMark Diagnostics, Inc. · Filed Jun 2, 2010

Insider Transaction Report

Form 4
Period: 2010-05-28
GLEESON CHRISTOPHER M
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-05-28+24,05024,050 total
    Exercise: $6.00Exp: 2020-05-27Common Stock (24,050 underlying)
Footnotes (2)
  • [F1]Options were granted with an exercise price equal to the initial public offering price of $6.00 per share contingent upon the pricing of the initial public offering.
  • [F2]This option vests and becomes exercisable in 12 equal monthly installments commencing on April 16, 2010.

Documents

1 file
  • 4
    rrd277648.xmlPrimary